Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and Company’s Code of Conduct for Insiders’, Ajanta pharma has informed that the Trading Window for dealing in securities of the Company shall remain closed for Designated Persons (as defined in the Code) from close of business hours of 31st March 2022 till 48 hours after the declaration of Financial Results of the Company for the quarter and year ended 31st March 2022.
The above information is a part of company’s filings submitted to BSE.
